Cargando…

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study

AIMS: To characterize comparative risks and benefits of methadone versus buprenorphine/naloxone in a contemporary cohort where the unregulated drug supply is dominated by fentanyl. DESIGN, SETTING AND PARTICIPANTS: Population‐based propensity‐score matched cohort study conducted in Ontario, Canada a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Tara, McCormack, Daniel, Bozinoff, Nikki, Tadrous, Mina, Antoniou, Tony, Munro, Charlotte, Campbell, Tonya, Paterson, J. Michael, Mamdani, Muhammad, Sproule, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313829/ https://www.ncbi.nlm.nih.gov/pubmed/35257434 http://dx.doi.org/10.1111/add.15862

Ejemplares similares

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
por: Kitchen, Sophie A., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
por: Garg, Ria, et al.
Publicado: (2022)

Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
por: Gomes, Tara, et al.
Publicado: (2021)

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
por: Antoniou, Tony, et al.
Publicado: (2022)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study
por: Choremis, Beatrice, et al.
Publicado: (2019)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada
por: Fenna, Jennifer, et al.
Publicado: (2021)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis
por: Chang, Ann, et al.
Publicado: (2022)

Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
por: Bozinoff, Nikki, et al.
Publicado: (2022)

The Effects of Methadone and Buprenorphine on Testis of Rats
por: Corsi, Karen F.
Publicado: (2012)

The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive study
por: Campbell, Tonya J., et al.
Publicado: (2023)

Correction: Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
por: Bozinoff, Nikki, et al.
Publicado: (2022)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
por: Richert, Torkel, et al.
Publicado: (2013)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada
por: Eibl, Joseph K., et al.
Publicado: (2015)

Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates
por: Peterman, Nicholas J, et al.
Publicado: (2022)

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study
por: Tadrous, Mina, et al.
Publicado: (2018)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
por: Gomes, Tara, et al.
Publicado: (2022)

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
por: Wapf, Victoria, et al.
Publicado: (2008)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review
por: Sritapan, Yasmin, et al.
Publicado: (2020)

Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
por: Delorme, Jessica, et al.
Publicado: (2021)

Clinical Case Conference: Strategies for Transferring From Methadone to Buprenorphine
por: Hill, Duncan, et al.
Publicado: (2022)

Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices
por: Shan, Xiaoyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tudp24b18cjsp0e66k67pufa36